CNS Pharmaceuticals, Inc. — Director's Dealing 2020

Jun 16, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CNS Pharmaceuticals, Inc. (CNSP)
CIK: 0001729427
Period of Report: 2020-06-12

Reporting Person: Gumulka Jerzy (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-12	Option to purchase common stock	$2.47	A	46559	Acquired	2030-06-12	Common Stock (46559)	Direct

Footnotes

F1: The stock options set forth in this table vest on the earlier of the one-year anniversary of the issuance date or the date of the 2021 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

F2: The stock options were issued in connection with the reporting person's Board of Director services to the Company.